early stage – Page 4 – Communicable Diseases Research

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients

Article

Published on 2022-09-262022-11-15
Journal: Frontiers in Immunology [Category] SARS, 바이오마커,

Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories

Article

Published on 2022-09-242022-11-16
Journal: BMC Public Health [Category] SARS, 유전자 메커니즘,

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Article

Published on 2022-09-232022-11-15
Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, 치료기술, 치료제,

[키워드] Antiviral B.1.1.529 changed cohorts cohorts of patient COVID-19 COVID-19 in patient CVID dominant early stage elevated Fatality rate General population Hospitalization immunodeficiency immunodeficient patient Impact improvement inborn errors of immunity individual Intervention monoclonal antibody morbidity and mortality Mortality MOST naïve nasopharynx omicron outcome pandemic Patient patients PCR PID Primary Immunodeficiency reduced risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine secondary immunodeficiency serological response severe COVID-19 shown significantly significantly increased the SARS-CoV-2 Treatment treatment strategy United Kingdom vaccination vaccine dose variant Viral detection viral variant widespread
[DOI] 10.3389/fimmu.2022.984376 PMC 바로가기

Development and validation of chest CT-based imaging biomarkers for early stage COVID-19 screening

Article

Published on 2022-09-212022-11-15
Journal: Frontiers in Public Health [Category] SARS, 바이오마커,

Evolving trend change during the COVID-19 pandemic

Article

Published on 2022-09-202022-11-16
Journal: Frontiers in Public Health [Category] SARS, 변종,

Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions

Article

Published on 2022-09-192022-11-15
Journal: PLoS Pathogens [Category] SARS, 치료제,

Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters

Article

Published on 2022-09-172022-11-15
Journal: Viruses [Category] SARS, 진단,

[키워드] angiotensin-converting enzyme 2 Blood controls coronavirus disease Coronavirus disease 2019 COVID-19 days post-infection disease early stage Efficacy exhibited favor fibrosis form hamster hamsters hepatocyte ballooning impair induce infected with SARS-CoV-2 Infection Inflammation Inflammatory cytokines less liver Liver fibrosis liver steatosis long-lasting Lung inflammation lung viral load mechanism NASH non-alcoholic steatohepatitis obese obese patient obesity pathophysiologic Patient pulmonary fibrosis relative replicate SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected hamsters Serum level severity of COVID-19 steatohepatitis sustained systemic inflammation the SARS-CoV-2 Treatment weight loss
[DOI] 10.3390/v14092067 PMC 바로가기

Differences in Clinical Presentations of Omicron Infections with the Lineages BA.2 and BA.5 in Mecklenburg-Western Pomerania, Germany, between April and July 2022

Article

Published on 2022-09-132022-11-16
Journal: Viruses [Category] SARS, 변종,

Fatality assessment and variant risk monitoring for COVID-19 using three new hospital occupancy related metrics

Research article

Published on 2022-09-012022-10-05
Journal: EBioMedicine [Category] SARS, 변종, 유전자 메커니즘, 치료기술,

Quantitative analysis of RT-PCR test results for SARS-CoV-2 diagnostics across Poland during COVID-19 pandemic: Comparison between early stage and major pandemic waves in 2020 and 2021 with reference to SARS-CoV-2 variants

Article

Published on 2022-09-012022-11-15
Journal: Advances in medical sciences [Category] SARS, 변종, 진단, 치료기술,